The evaluation of YKL-40 expression was defined according to the percent and/or intensity of YKL-40 staining in tumor cells by IHC as well as a determinate cut-off value of serum YKL-40 level by RIA or ELISA. The gene discussed is CHI3L1; the disease is neoplasm.